Ciprofloxacin and imipenem alone or in combination in experimental aortic valve endocarditis due to a ciprofloxacin borderline susceptible strain of Pseudomonas aeruginosa.

[1]  I. Donta,et al.  Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis , 1993, Antimicrobial Agents and Chemotherapy.

[2]  K. Shaw,et al.  Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance). , 1990, The Journal of antimicrobial chemotherapy.

[3]  P. Kalmar,et al.  Pharmacokinetic behavior of ciprofloxacin both in native cardiac and porcine valves treated in glutaraldehyde. , 1990, Diagnostic microbiology and infectious disease.

[4]  A. Bayer,et al.  Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis , 1989, Antimicrobial Agents and Chemotherapy.

[5]  M. Levison,et al.  Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin. , 1988, The Journal of infectious diseases.

[6]  G. Jackson,et al.  Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis. , 1988, The American journal of medicine.

[7]  A. Bayer,et al.  Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis , 1988, Antimicrobial Agents and Chemotherapy.

[8]  H. Giamarellou,et al.  Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa , 1987, Antimicrobial Agents and Chemotherapy.

[9]  K. Kim,et al.  Characterization of impermeability variants of Pseudomonas aeruginosa isolated during unsuccessful therapy of experimental endocarditis , 1987, Antimicrobial Agents and Chemotherapy.

[10]  A. Bayer,et al.  Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production , 1986, Antimicrobial Agents and Chemotherapy.

[11]  K. Kim,et al.  Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa. , 1986, The Journal of antimicrobial chemotherapy.

[12]  M. Lederman,et al.  Left‐Sided Endocarditis due to Pseudomonas aeruginosa: A REPORT OF 10 CASES AND REVIEW OF THE LITERATURE , 1986, Medicine.

[13]  M. Levison,et al.  The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat. , 1986, The Journal of infectious diseases.

[14]  K. Godfrey.  Comparing the Means of Several Groups , 1985, Medical Uses of Statistics.

[15]  A S Bayer,et al.  Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa , 1985, Antimicrobial Agents and Chemotherapy.

[16]  R. Maserati,et al.  Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis , 1985, Antimicrobial Agents and Chemotherapy.

[17]  E. Freimer,et al.  Pathogenesis and treatment of endocarditis. , 1985, The American journal of medicine.

[18]  A. Lerner,et al.  Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. , 1983, Reviews of infectious diseases.

[19]  W. J. Brown,et al.  TREATMENT OF PATIENTS WITH PSEUDOMONAS ENDOCARDITIS WITH HIGH DOSE AMINOGLYCOSIDE AND CARBENICILLIN THERAPY , 1978, Medicine.

[20]  F. Fekety,et al.  Experimental endocarditis due to Pseudomonas aeruginosa. II. Therapy with carbenicillin and gentamicin. , 1977, The Journal of infectious diseases.

[21]  F. Fekety,et al.  Experimental endocarditis due to Pseudomonas aeruginosa. I. Description of a model. , 1976, The Journal of infectious diseases.

[22]  L. Young,et al.  Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. , 1972, The Journal of infectious diseases.

[23]  B. Perlman,et al.  Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. , 1971, The Yale journal of biology and medicine.

[24]  C. Fichtenbaum,et al.  Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem. , 1992, Clinical Infectious Diseases.

[25]  C. Nast,et al.  Oxygen-dependent differences in exopolysaccharide production and aminoglycoside inhibitory-bactericidal interactions with Pseudomonas aeruginosa--implications for endocarditis. , 1989, The Journal of antimicrobial chemotherapy.

[26]  J. Breuer,et al.  The possible role of ciprofloxacin in the treatment of endocarditis caused by Pseudomonas aeruginosa. , 1988, Journal of Infection.

[27]  S. Glantz.  Primer of biostatistics : statistical software program version 6.0 , 1981 .